Advances in ß-Thalassemia: From Molecular Biology to Clinical Practice

Beta-thalassemia (ß-thalassemia) is an autosomal recessive disorder of haemoglobin inheritance resulting due to mutations of HBB gene present on chromosome 11 that lead to quantitative deficiency of ß-globin chains. The defect results in the accumulation of unpaired α-globin chains, inducing high rates of apoptosis in erythroid precursors, ineffective erythropoiesis, severe anaemia and progressive systemic iron overload. The conventional clinical approach is lifelong blood transfusion with regular iron chelation therapy but patients remain at risk of secondary organ toxicity. This review delineates the rapid paradigm shift in management of ß-thalassemia from conventional, supportive strategies toward personalised precision medicine. It discusses critical modern diagnostic methodologies, such as high- performance liquid chromatography (HPLC) and multiplex ligation-dependent probe amplification (MLPA), alongside pioneering therapeutic interventions. This paper reviews the clinical efficacy, regulatory milestones and mechanisms of action of the recently FDA-approved autologous hematopoietic stem cell gene therapies and CRISPR/Cas9-based gene-editing systems. It also discusses new targeted drug therapies and novel hepcidin-ferroportin axis modulators. It highlights important implementation challenges, including high costs of treatment, disparities in access across the world, and the integration of multi-omics data, and emphasizes the pathways needed to translate these advanced genomic innovations into accessible curative clinical standards on a global scale.

Authors

Institutions

Publication Details

Journal
The American Journal of Applied Sciences
Published
2026-11-12
DOI
https://doi.org/10.37547/tajas/warm-34
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Advances in ß-Thalassemia: From Molecular Biology to Clinical Practice

Sayali Mukherjee, Pragya Mishra
The American Journal of Applied Sciences
Hemoglobinopathies and Related Disorders
article

Advances in ß-Thalassemia: From Molecular Biology to Clinical Practice

Sayali Mukherjee, Pragya Mishra
article en

Abstract

Beta-thalassemia (ß-thalassemia) is an autosomal recessive disorder of haemoglobin inheritance resulting due to mutations of HBB gene present on chromosome 11 that lead to quantitative deficiency of ß-globin chains. The defect results in the accumulation of unpaired α-globin chains, inducing high rates of apoptosis in erythroid precursors, ineffective erythropoiesis, severe anaemia and progressive systemic iron overload. The conventional clinical approach is lifelong blood transfusion with regular iron chelation therapy but patients remain at risk of secondary organ toxicity. This review delineates the rapid paradigm shift in management of ß-thalassemia from conventional, supportive strategies toward personalised precision medicine. It discusses critical modern diagnostic methodologies, such as high- performance liquid chromatography (HPLC) and multiplex ligation-dependent probe amplification (MLPA), alongside pioneering therapeutic interventions. This paper reviews the clinical efficacy, regulatory milestones and mechanisms of action of the recently FDA-approved autologous hematopoietic stem cell gene therapies and CRISPR/Cas9-based gene-editing systems. It also discusses new targeted drug therapies and novel hepcidin-ferroportin axis modulators. It highlights important implementation challenges, including high costs of treatment, disparities in access across the world, and the integration of multi-omics data, and emphasizes the pathways needed to translate these advanced genomic innovations into accessible curative clinical standards on a global scale.

The American Journal of Applied SciencesVol. 8(11)
Amity University (IN)
Good health and well-being
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon